118 related articles for article (PubMed ID: 8143238)
41. Combination therapies that inhibit cyclooxygenase-2 and leukotriene synthesis prevent disease in murine collagen induced arthritis.
Anderson GD; Keys KL; De Ciechi PA; Masferrer JL
Inflamm Res; 2009 Feb; 58(2):109-17. PubMed ID: 19184362
[TBL] [Abstract][Full Text] [Related]
42. Leukotriene synthesis inhibition and anti-ige challenge of human lung parenchyma.
Gorenne I; Alaoui HS; Gascard JP; Labat C; Norel X; De Montpreville V; Brink C
Life Sci; 1996; 59(13):PL213-9. PubMed ID: 8809230
[TBL] [Abstract][Full Text] [Related]
43. Synthesis of indolylalkoxyiminoalkylcarboxylates as leukotriene biosynthesis inhibitors.
Kolasa T; Bhatia P; Brooks CD; Hulkower KI; Bouska JB; Harris RR; Bell RL
Bioorg Med Chem; 1997 Mar; 5(3):507-14. PubMed ID: 9113329
[TBL] [Abstract][Full Text] [Related]
44. Etoricoxib (MK-0663): preclinical profile and comparison with other agents that selectively inhibit cyclooxygenase-2.
Riendeau D; Percival MD; Brideau C; Charleson S; Dubé D; Ethier D; Falgueyret JP; Friesen RW; Gordon R; Greig G; Guay J; Mancini J; Ouellet M; Wong E; Xu L; Boyce S; Visco D; Girard Y; Prasit P; Zamboni R; Rodger IW; Gresser M; Ford-Hutchinson AW; Young RN; Chan CC
J Pharmacol Exp Ther; 2001 Feb; 296(2):558-66. PubMed ID: 11160644
[TBL] [Abstract][Full Text] [Related]
45. Distinct pathways of lipopolysaccharide priming of human neutrophil respiratory burst: role of lipid mediator synthesis and sensitivity to interleukin-10.
Sibelius U; Hattar K; Hoffmann S; Mayer K; Grandel U; Schenkel A; Seeger W; Grimminger F
Crit Care Med; 2002 Oct; 30(10):2306-12. PubMed ID: 12394960
[TBL] [Abstract][Full Text] [Related]
46. Suppression of experimental autoimmune encephalomyelitis by a new specific inhibitor of leukotriene biosynthesis.
Neu IS; Wildfeuer A; Mallinger J; Mehlber L
Arzneimittelforschung; 1992 Sep; 42(9):1083-6. PubMed ID: 1332726
[TBL] [Abstract][Full Text] [Related]
47. Dual acting anti-inflammatory drugs: a reappraisal.
Bertolini A; Ottani A; Sandrini M
Pharmacol Res; 2001 Dec; 44(6):437-50. PubMed ID: 11735348
[TBL] [Abstract][Full Text] [Related]
48. Modulation by lipid mediators of immune complex-induced lung inflammation in mice.
Steil AA; Tavares de Lima W; Jancar S
Eur J Pharmacol; 1998 Nov; 361(1):93-9. PubMed ID: 9851546
[TBL] [Abstract][Full Text] [Related]
49. Involvement of leukotriene B(4) in substance P-induced itch-associated response in mice.
Andoh T; Katsube N; Maruyama M; Kuraishi Y
J Invest Dermatol; 2001 Dec; 117(6):1621-6. PubMed ID: 11886531
[TBL] [Abstract][Full Text] [Related]
50. Effect of FLAP antagonist MK-0591 on leukotriene production and ozone-induced airway responses in dogs.
Stevens WH; Lane CG; Woolley MJ; Ellis R; Tagari P; Black C; Ford-Hutchinson A; O'Byrne PM
J Appl Physiol (1985); 1994 Apr; 76(4):1583-8. PubMed ID: 8045835
[TBL] [Abstract][Full Text] [Related]
51. Exacerbation of experimental colitis by nonsteroidal anti-inflammatory drugs is not related to elevated leukotriene B4 synthesis.
Wallace JL; Keenan CM; Gale D; Shoupe TS
Gastroenterology; 1992 Jan; 102(1):18-27. PubMed ID: 1309357
[TBL] [Abstract][Full Text] [Related]
52. The pharmacologic effects of 5-[3,5-bis(1,1-dimethylethyl)-4- hydroxyphenyl]-1,3,4-thiadiazole-2(3H)-thione, choline salt (CI-986), a novel inhibitor of arachidonic acid metabolism in models of inflammation, analgesia and gastric irritation.
Schrier DJ; Baragi VM; Connor DT; Dyer RD; Jordan JH; Imre KM; Lesch ME; Mullican MD; Okonkwo GC; Conroy MC
Prostaglandins; 1994 Jan; 47(1):17-30. PubMed ID: 8140259
[TBL] [Abstract][Full Text] [Related]
53. 5-Lipoxygenase-activating protein is the target of a quinoline class of leukotriene synthesis inhibitors.
Evans JF; Lévillé C; Mancini JA; Prasit P; Thérien M; Zamboni R; Gauthier JY; Fortin R; Charleson P; MacIntyre DE
Mol Pharmacol; 1991 Jul; 40(1):22-7. PubMed ID: 1857337
[TBL] [Abstract][Full Text] [Related]
54. Intestinal effects of nonselective and selective cyclooxygenase inhibitors in the rat.
Menozzi A; Pozzoli C; Giovannini E; Solenghi E; Grandi D; Bonardi S; Bertini S; Vasina V; Coruzzi G
Eur J Pharmacol; 2006 Dec; 552(1-3):143-50. PubMed ID: 17069793
[TBL] [Abstract][Full Text] [Related]
55. Effects of boswellic acids extracted from a herbal medicine on the biosynthesis of leukotrienes and the course of experimental autoimmune encephalomyelitis.
Wildfeuer A; Neu IS; Safayhi H; Metzger G; Wehrmann M; Vogel U; Ammon HP
Arzneimittelforschung; 1998 Jun; 48(6):668-74. PubMed ID: 9689425
[TBL] [Abstract][Full Text] [Related]
56. Mode of action of the new selective leukotriene synthesis inhibitor BAY X 1005 ((R)-2-[4-(quinolin-2-yl-methoxy)phenyl]-2-cyclopentyl acetic acid) and structurally related compounds.
Hatzelmann A; Fruchtmann R; Mohrs KH; Raddatz S; Müller-Peddinghaus R
Biochem Pharmacol; 1993 Jan; 45(1):101-11. PubMed ID: 8381000
[TBL] [Abstract][Full Text] [Related]
57. The molecular mechanism of the inhibition by licofelone of the biosynthesis of 5-lipoxygenase products.
Fischer L; Hornig M; Pergola C; Meindl N; Franke L; Tanrikulu Y; Dodt G; Schneider G; Steinhilber D; Werz O
Br J Pharmacol; 2007 Oct; 152(4):471-80. PubMed ID: 17704828
[TBL] [Abstract][Full Text] [Related]
58. The lipoxygenase inhibitor, nordihydroguaiaretic acid, inhibits ovulation and reduces leukotriene and prostaglandin levels in the rat ovary.
Mikuni M; Yoshida M; Hellberg P; Peterson CA; Edwin SS; Brännström M; Peterson CM
Biol Reprod; 1998 May; 58(5):1211-6. PubMed ID: 9603255
[TBL] [Abstract][Full Text] [Related]
59. Arachidonic acid induces DNA-fragmentation in human polymorphonuclear neutrophil granulocytes.
Köller M; Wachtler P; Dávid A; Muhr G; König W
Inflammation; 1997 Oct; 21(5):463-74. PubMed ID: 9343745
[TBL] [Abstract][Full Text] [Related]
60. Leukotriene synthesis by human gastrointestinal tissues.
Dreyling KW; Hoppe U; Peskar BA; Morgenroth K; Kozuschek W; Peskar BM
Biochim Biophys Acta; 1986 Sep; 878(2):184-93. PubMed ID: 3019409
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
